XML 35 R24.htm IDEA: XBRL DOCUMENT
v3.25.3

Summary of Significant Accounting Policies (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Accounting Policies [Abstract] |
Schedule of Disaggregation of Revenue | The following table presents disaggregation of revenue by Prenatal, Oncology and Clinical trial support and other services for the three and nine months ended September 30, 2025 and 2024 (in thousands):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Prenatal | $ | 74,071 |  |  | $ | 36,601 |  |  | $ | 191,001 |  |  | $ | 102,680 |
Oncology | 8,691 |  |  | 1,138 |  |  | 15,814 |  |  | 1,851 |
Clinical trial support and other services | 761 |  |  | 680 |  |  | 2,244 |  |  | 2,974 |
Total revenues | $ | 83,523 |  |  | $ | 38,419 |  |  | $ | 209,059 |  |  | $ | 107,505 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 + Details
Name: | us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration